HOME >> BIOLOGY >> NEWS
Alzheimer's drug based on Purdue -- designed inhibitor begins clinical trials

WEST LAFAYETTE, Ind. - A drug based on the design of a Purdue University researcher to treat Alzheimer's disease began the first phase of human clinical trials this week.

"Millions of people suffer from this devastating disease and treatment options are very limited," said Arun Ghosh, the Purdue professor who led the creation of the treatment molecule. "Current drugs manage the symptoms, but this could be the first disease-modifying therapy. It may be able to prevent and reverse the disease."

CoMentis Inc., a biopharmaceutical company based in San Francisco, is initiating the clinical trials of the experimental drug CTS-21166. Ghosh, who has dual appointments in the departments of chemistry and medicinal chemistry, is a scientific co-founder of the company with Jordan Tang, the J.G. Puterbaugh Chair in Medical Research at the Oklahoma Medical Research Foundation.

The collaborative work of Ghosh and Tang led to the development of a treatment that could intercept and disable the disease at an early stage.

In 2000, Tang identified beta-secretase, a key enzyme in the progression of Alzheimer's that triggers the formation of amyloid plaques in the brain. Various stages in plaque formation produce toxic proteins that harm the brain, causing damage that eventually leads to dementia.

Later that year, Ghosh built a molecule that binds to this key enzyme and inhibits its activity, a beta-secretase inhibitor.

"These molecules fit together like puzzle pieces," Ghosh said. "We created a molecule that fits with a key piece of the Alzheimer's disease puzzle. When the treatment molecule binds to the enzyme, it changes the shape of that puzzle piece so that it no longer fits in its original spot. This halts the chain reaction that leads to the devastating symptoms of Alzheimer's disease."

Since 2000, Ghosh has been leading the structure-based design of beta-secreatase inhibitors for therapeutic interventio
'"/>

Contact: Elizabeth Gardner
ekgardner@purdue.edu
765-494-2081
Purdue University
22-Jun-2007


Page: 1 2

Related biology news :

1. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
2. Link identified between Alzheimers disease and glaucoma
3. UCF research links proteins, stem cells and potential Alzheimers treatment
4. Journal of Alzheimers Disease achieves significant impact factor
5. Alzheimers prevention role discovered for prions
6. Cloned pigs help scientists towards a breakthrough in Alzheimers
7. Paving the way toward a vaccine against Alzheimers disease
8. Genetic fellow traveler discovered in Alzheimers
9. New clues to stroke role in Alzheimers
10. Research team identifies new Alzheimers gene
11. What causes Alzheimers? Researchers tie beta-amyloids to brain dysfunction

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2020)... ... , ... Join experts from Envigo Lauren Klaskala, Project Manager – ... on Wednesday, July 8, 2020 at 11am EDT (4pm BST/UK). , Nuclease-based technologies ... However, while modifying the genome may be more straightforward, the challenge to create an ...
(Date:6/11/2020)... ... 09, 2020 , ... Superior Controls, Inc. , an E Technologies Company ... the life sciences industry, is pleased to announce the recent hiring of Ray Boudreau, ... Seabrook, New Hampshire office. In his new role, Boudreau will use his extensive ...
(Date:6/5/2020)... ... 04, 2020 , ... Greffex, a pioneering vaccine and gene therapy company based ... understands the need for a global perspective to make an impact in a post ... will serve as an independent, director of the company. , “The Greffex board is ...
Breaking Biology News(10 mins):
(Date:5/26/2020)... ... 2020 , ... Brilliant , the leading smart home control and lighting ... announce a new integration to bring more convenience, simplicity, and security to the smart ... Connect® can now be controlled from Brilliant’s in-wall touchscreen control panels and mobile app. ...
(Date:5/21/2020)... ... 19, 2020 , ... Experienced periodontist in Eden Prairie, MN, Dr. Andres Sanchez, ... through PIEZOSURGERY® technology. PIEZOSURGERY uses ultrasonic vibrations to gently cut bone in ... for dental implants, especially when the implants need to be placed in a sensitive ...
(Date:5/21/2020)... Calif. (PRWEB) , ... May 20, 2020 , ... ... the addition of Simon Prakash, who will serve as the company’s executive vice ... at a time when Exo is disrupting the medical imaging space, bringing more ...
(Date:5/15/2020)... ... May 14, 2020 , ... Children with defective heart valves ... before becoming adults. The reason: there are no heart valve prosthetics designed to ... Department of Defense has awarded Draper, Boston Children’s Hospital and Seattle Children’s Research ...
Breaking Biology Technology:
Cached News: